Cambridge-based Infersens has launched Cortense, its first commercially available solution to transform Legionella risk management and dramatically cut water waste.
Legionella bacteria, which can multiply in stagnant water systems, poses a serious risk to human health, and must be prevented to protect against harmful disease outbreaks. However, traditional techniques like tap flushing and manual temperature checks can be resource-intensive, unreliable, and prone to human error.
Cortense is a precision water monitoring solution for both flow and temperature, and additionally contributes to sustainable practices to reduce emissions and conserve natural resources (including water).
The water monitoring solution – the winner of two innovation awards last year [2023] – relies on a unique battery-powered tinyML sensing technology to solve the power and performance issues affecting alternative systems.
The company says the small, wireless devices are easy to install on water pipes anywhere within a building. Once in place, they provide real-time coverage of flow and temperature within your water system. The data is collected and recorded in a centralised dashboard, providing operators with easy access to the information 24/7.
With Cortense, property owners, facilities managers and sustainability leads should be able to efficiently monitor Legionella risk factors, deploy resources effectively and cut water waste.
The product launch follows seven years of R&D and use case development with public and commercial properties in the UK. It coincides with a funding announcement by Wave, a national water retailer, who are using Cortense in a two-year, 1,000-device deployment project to automate and optimise Legionella risk monitoring tasks, support regulatory compliance, improve resource efficiency, and reduce water waste.
Infersens CEO, Jana Voigt said:
“Our initial funding rounds enabled us to complete the development and pilot the technology, and this first solution launch enables us to take our product to more companies on commercial trials as we have with Wave. We couldn’t be more excited to be transforming Legionella risk management and contributing directly to the reduction of water waste.”
